Biological characteristics of cancers in the gallbladder and biliary tract and targeted therapyTHOMAS, Melanie B.Critical reviews in oncology/hematology. 2007, Vol 61, Num 1, pp 44-51, issn 1040-8428, 8 p.Article

Gemcitabine in advanced biliary tract cancersPASETTO, Lara Maria; D'ANDREA, Mario Rosario; FALCI, Cristina et al.Critical reviews in oncology/hematology. 2007, Vol 61, Num 3, pp 230-242, issn 1040-8428, 13 p.Article

Indication of hepatopancreatoduodenectomy for biliary tract cancerHIRONO, Seiko; TANI, Masaji; KAWAI, Manabu et al.World journal of surgery. 2006, Vol 30, Num 4, pp 567-575, issn 0364-2313, 9 p.Article

Single-agent gemcitabine for biliary tract cancers : Study outcomes and systematic review of the literatureKIBA, Takayoshi; NISHIMURA, Tsutomu; YOSHIKAWA, Kiyotsugu et al.Oncology. 2006, Vol 70, Num 5, pp 358-365, issn 0030-2414, 8 p.Article

Phase II study of single-agent gemcitabine in patients with advanced biliary tract cancerOKUSAKA, Takuji; ISHII, Hiroshi; FUNAKOSHI, Akihiro et al.Cancer chemotherapy and pharmacology. 2006, Vol 57, Num 5, pp 647-653, issn 0344-5704, 7 p.Article

CYP17 MspA1 polymorphism and risk of biliary tract cancers and gallstones : A population-based study in Shanghai, ChinaLIFANG HOU; JIANFENG XU; ZHANG, Bai-He et al.International journal of cancer. 2006, Vol 118, Num 11, pp 2847-2853, issn 0020-7136, 7 p.Article

CPT-11 (SN-38) chemotherapy may be selectively applicable to biliary tract cancer with low hMLH1 expressionSATO, Ken; KITAJIMA, Yoshihiko; KOHYA, Naohiko et al.Anticancer research. 2007, Vol 27, Num 2, pp 865-872, issn 0250-7005, 8 p.Article

Deficient expression of the DPD gene is caused by epigenetic modification in biliary tract cancer cells, and induces high sensitivity to 5-FU treatmentSATO, Ken; KITAJIMA, Yoshihiko; MIYOSHI, Atsushi et al.International journal of oncology. 2006, Vol 29, Num 2, pp 429-435, issn 1019-6439, 7 p.Article

Family history of gallstones and the risk of biliary tract cancer and gallstones : A population-based study in Shanghai, ChinaHSING, Ann W; YAN BAI; GAO, Yu-Tang et al.International journal of cancer. 2007, Vol 121, Num 4, pp 832-838, issn 0020-7136, 7 p.Article

Trends in the incidence and management of biliary tract cancer: A French population-based studyLEPAGE, Côme; COTTET, Vanessa; CHAUVENET, Marion et al.Journal of hepatology. 2011, Vol 54, Num 2, pp 306-310, issn 0168-8278, 5 p.Article

Prognostic factors in patients with advanced biliary tract cancer receiving chemotherapySAISHO, Toshimitsu; OKUSAKA, Takuji; UENO, Hideki et al.Hepato-gastroenterology. 2005, Vol 52, Num 66, pp 1654-1658, issn 0172-6390, 5 p.Article

Expression ofp21 and p27 in gallbladder cancerALSHEYAB, Fawzi M; ZIADEH, Moroug T; BANI-HANI, Kamal E et al.Saudi medical journal. 2007, Vol 28, Num 5, pp 683-687, issn 0379-5284, 5 p.Article

S-1 Monotherapy in Patients with Advanced Biliary Tract CancerSASAKI, Takashi; ISAYAMA, Hiroyuki; SASAHIRA, Naoki et al.Oncology. 2009, Vol 77, Num 1, pp 71-74, issn 0030-2414, 4 p.Article

Phase II study of capecitabine and cisplatin in previously untreated advanced biliary tract cancerYONG SANG HONG; LEE, Jeeyun; SANG CHEOL LEE et al.Cancer chemotherapy and pharmacology. 2007, Vol 60, Num 3, pp 321-328, issn 0344-5704, 8 p.Article

Significance of Keratinocyte Growth Factor Receptor in the Proliferation of Biliary Tract CancerAMINO, Ryosuke; YAMADA, Nobuya; DOI, Yosuke et al.Anticancer research. 2010, Vol 30, Num 10, pp 4115-4121, issn 0250-7005, 7 p.Article

Restoration of RUNX3 enhances transforming growth factor-β-dependent p21 expression in a biliary tract cancer cell lineHASEGAWA, Kazunori; YAZUMI, Shujiro; SAKAKURA, Chohei et al.Cancer science. 2007, Vol 98, Num 6, pp 838-843, issn 1347-9032, 6 p.Article

hOGG1 Ser326Cys polymorphism and susceptibility to gallbladder cancer in a Chinese populationXINGYUAN JIAO; JIEFU HUANG; SHENGLI WU et al.International journal of cancer. 2007, Vol 121, Num 3, pp 501-505, issn 0020-7136, 5 p.Article

Does laparoscopy worsen the prognosis for incidental gallbladder cancer?GOETZE, T; PAOLUCCI, V.Surgical endoscopy. 2006, Vol 20, Num 2, pp 286-293, issn 0930-2794, 8 p.Article

Cancer de la vesicule biliaire decouvert apres cholecystectomie pour pathologie vesiculaire benigne : Que faire ? = Gallbladder cancer dis covred after cholecystectomy for begnin diseases : What should we do?MISSAOUI, Kéfi; HOUISSA, Hichem; BEN SLIMA, Mohamed et al.Tunisie chirurgicale. 2005, Num 3, pp 155-158, issn 0330-5961, 4 p.Article

A novel electrochemical immunosensor for Golgi Protein 73 assayYUE YU; TAO GAO; HAO LI et al.Electrochemistry communications. 2014, Vol 42, pp 6-8, issn 1388-2481, 3 p.Article

A pilot study of S-1-based concurrent chemoradiotherapy in patients with biliary tract cancerHEE MAN KIM; KYONG JOO LEE; JIHYE CHA et al.Cancer chemotherapy and pharmacology. 2014, Vol 74, Num 4, pp 861-865, issn 0344-5704, 5 p.Article

Significance of extensive surgery including resection of the pancreas head for the treatment of gallbladder cancer : From the perspective of mode of lymph node involvement and surgical outcomeSASAKI, Ryoko; ITABASHI, Hidenori; FUJITA, Tomohiro et al.World journal of surgery. 2006, Vol 30, Num 1, pp 36-42, issn 0364-2313, 7 p.Article

Thymidylate synthase and dihydropyrimidine dehydrogenase expressions in gallbladder cancerAJIKI, Tetsuo; HIRATA, Kenro; OKAZAKI, Taro et al.Anticancer research. 2006, Vol 26, Num 2B, pp 1391-1396, issn 0250-7005, 6 p.Article

MUC1 peptide vaccination in patients with advanced pancreas or biliary tract cancerYAMAMOTO, Kotaro; UENO, Tomio; HINODA, Yuji et al.Anticancer research. 2005, Vol 25, Num 5, pp 3575-3579, issn 0250-7005, 5 p.Article

Controversies in the surgical management of cholangiocarcinoma and gallbladder cancerSICKLICK, Jason K; CHOTI, Michael A.Seminars in oncology. 2005, Vol 32, Num 6, issn 0093-7754, S112-S117, SUP9Conference Paper